OS-007 E2F1-driven metabolic dysregulation is involved in hippo pathway-driven cholangiocarcinoma progression

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-05-01 DOI:10.1016/S0168-8278(25)00322-8

Kendall Alfaro-Jiménez, Mikel Ruiz de Gauna, Ane Nieva-Zuluaga, Maider Apodaka-Biguri, Irene Olaizola, Enara Markaide, Laura Izquierdo-Sánchez, Colin Rae, Francisco González-Romero, Paul Gómez-Jauregui, Natalia Sainz-Ramirez, Beatriz Gómez Santos, Xabier Buque, Igor Aurrekoetxea, Igotz Delgado, Idoia Fernández-Puertas, Ainhoa Iglesias, Colm O. Rourke, Pedro M. Rodrigues, Jesper Andersen, Patricia Aspichueta

引用次数: 0

查看原文本刊更多论文

OS-007 e2f1驱动的代谢失调参与了河马通路驱动的胆管癌进展

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.